Guggenheim Capital LLC Geron Corp Transaction History
Guggenheim Capital LLC
- $10.6 Billion
- Q1 2025
A detailed history of Guggenheim Capital LLC transactions in Geron Corp stock. As of the latest transaction made, Guggenheim Capital LLC holds 212,699 shares of GERN stock, worth $295,651. This represents 0.0% of its overall portfolio holdings.
Number of Shares
212,699
Previous 214,828
0.99%
Holding current value
$295,651
Previous $760,000
55.53%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding GERN
# of Institutions
295Shares Held
496MCall Options Held
799KPut Options Held
463K-
Ra Capital Management, L.P. Boston, MA60.4MShares$83.9 Million1.99% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$64.7 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT38.2MShares$53.1 Million2.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA34.1MShares$47.5 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$37.8 Million11.75% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $525M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...